Cite
HARVARD Citation
Kopylov, U. et al. (n.d.). DOP001 Effectiveness and safety of vedolizumab in anti-TNF naïve patients with inflammatory bowel disease: a multicentre retrospective European Crohn's and Colitis Organisation study. Journal of Crohn's and colitis. pp. S029-S030. [Online].